Autumn Glory Partners’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86M Hold
9,572
0.81% 33
2026
Q1
$2.61M Buy
9,572
+1,025
+12% +$293K 0.96% 24
2025
Q4
$2.46M Buy
8,547
+172
+2% +$48.1K 0.86% 29
2025
Q3
$2.17M Hold
8,375
0.89% 30
2025
Q2
$2.08M Hold
8,375
0.97% 26
2025
Q1
$2.22M Hold
8,375
1.1% 23
2024
Q4
$2.12M Sell
8,375
-300
-3% -$80.8K 1.04% 26
2024
Q3
$2.45M Hold
8,675
0.94% 31
2024
Q2
$2.31M Hold
8,675
1.18% 24
2024
Q1
$2.35M Hold
8,675
1.15% 24
2023
Q4
$2.22M Sell
8,675
-999
-10% -$237K 1.26% 20
2023
Q3
$2.27M Sell
9,674
-6,400
-40% -$1.56M 1.39% 18
2023
Q2
$2.29M Buy
16,074
+6,400
+66% +$1.56M 1.68% 15
2023
Q1
$2.31M Sell
9,674
-40
-0.4% -$9.63K 1.97% 15
2022
Q4
$2.41M Sell
9,714
-179
-2% -$43.4K 1.29% 21
2022
Q3
$2.21M Hold
9,893
1.49% 17
2022
Q2
$2.33M Buy
9,893
+4,259
+76% +$1.03M 1.72% 16
2022
Q1
$1.43M Buy
5,634
+1,152
+26% +$285K 0.83% 39
2021
Q4
$1.19M Buy
+4,482
New +$1.14M 0.5% 58

Other funds holding VHT

Autumn Glory Partners's VHT Position: Q2 2026 in Review

Autumn Glory Partners held its Vanguard Health Care ETF (VHT) position steady in Q2 2026 at 9,572 shares worth $2.86M. The position accounts for 0.81% of the portfolio, ranked #33.

Autumn Glory Partners first reported a position in VHT in Q4 2021 and has held it in 19 quarters since. 1,112 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Autumn Glory Partners held 9,572 shares of Vanguard Health Care ETF worth $2.86M as of Q2 2026.
  • Autumn Glory Partners left its Vanguard Health Care ETF share count unchanged in Q2 2026.
  • Vanguard Health Care ETF made up 0.81% of Autumn Glory Partners's portfolio in Q2 2026, its #33 holding.
  • Autumn Glory Partners first reported a position in Vanguard Health Care ETF in Q4 2021 and has held it in 19 quarters since.
  • 1,112 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.